M.B. Tyers

6.3k total citations · 1 hit paper
73 papers, 5.3k citations indexed

About

M.B. Tyers is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Physiology. According to data from OpenAlex, M.B. Tyers has authored 73 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 37 papers in Cellular and Molecular Neuroscience, 36 papers in Molecular Biology and 18 papers in Physiology. Recurrent topics in M.B. Tyers's work include Neuropeptides and Animal Physiology (24 papers), Receptor Mechanisms and Signaling (21 papers) and Pharmacological Receptor Mechanisms and Effects (20 papers). M.B. Tyers is often cited by papers focused on Neuropeptides and Animal Physiology (24 papers), Receptor Mechanisms and Signaling (21 papers) and Pharmacological Receptor Mechanisms and Effects (20 papers). M.B. Tyers collaborates with scholars based in United Kingdom, United States and Poland. M.B. Tyers's co-authors include Gavin J. Kilpatrick, R.J. Naylor, B. Costall, Brian Jones, Ann G. Hayes, S.J. Ireland, A.M. Domeney, M. Skingle, M.E. Kelly and K T Bunce and has published in prestigious journals such as Nature, Brain and Trends in Neurosciences.

In The Last Decade

M.B. Tyers

71 papers receiving 5.0k citations

Hit Papers

Identification and distri... 1987 2026 2000 2013 1987 200 400 600

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
M.B. Tyers 3.3k 2.4k 1.3k 822 560 73 5.3k
R.J. Naylor 4.7k 1.4× 2.8k 1.2× 1.0k 0.8× 968 1.2× 924 1.6× 174 8.1k
S. Bourgoin 4.2k 1.3× 2.1k 0.9× 2.8k 2.1× 396 0.5× 410 0.7× 160 5.8k
Manfred Göthert 3.5k 1.1× 3.3k 1.4× 1.0k 0.8× 310 0.4× 1.1k 2.0× 192 6.3k
Jean De Vry 3.3k 1.0× 1.8k 0.7× 1.5k 1.1× 321 0.4× 1.1k 2.0× 127 5.5k
Robert J. Naylor 2.9k 0.9× 2.0k 0.8× 571 0.4× 320 0.4× 518 0.9× 134 4.9k
Khem Jhamandas 3.4k 1.0× 2.0k 0.9× 1.9k 1.4× 303 0.4× 570 1.0× 154 5.1k
P.R. Saxena 2.4k 0.7× 2.1k 0.9× 1.0k 0.7× 327 0.4× 364 0.7× 53 5.0k
E. Leong Way 3.2k 1.0× 2.1k 0.9× 1.6k 1.2× 239 0.3× 403 0.7× 142 5.0k
S. Consolo 4.0k 1.2× 2.7k 1.1× 448 0.3× 516 0.6× 639 1.1× 137 4.9k
Thomas A. Rudy 3.4k 1.0× 1.6k 0.7× 4.7k 3.5× 1.2k 1.5× 478 0.9× 52 6.4k

Countries citing papers authored by M.B. Tyers

Since Specialization
Citations

This map shows the geographic impact of M.B. Tyers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M.B. Tyers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M.B. Tyers more than expected).

Fields of papers citing papers by M.B. Tyers

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by M.B. Tyers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M.B. Tyers. The network helps show where M.B. Tyers may publish in the future.

Co-authorship network of co-authors of M.B. Tyers

This figure shows the co-authorship network connecting the top 25 collaborators of M.B. Tyers. A scholar is included among the top collaborators of M.B. Tyers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with M.B. Tyers. M.B. Tyers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Skingle, M., David T. Beattie, D. I. C. SCOPES, et al.. (1995). GR127935: a potent and selective 5-HT1D receptor antagonist. Behavioural Brain Research. 73(1-2). 157–161. 155 indexed citations
2.
Stratton, Sharon C., et al.. (1993). Anxiolytic activity of tachykinin NK2 receptor antagonists in the mouse light-dark box. European Journal of Pharmacology. 250(3). R11–R12. 35 indexed citations
3.
Hagan, R.M., Gavin J. Kilpatrick, & M.B. Tyers. (1993). Interactions between 5-HT3 receptors and cerebral dopamine function: implications for the treatment of schizophrenia and psychoactive substance abuse. Psychopharmacology. 112(S1). S68–S75. 45 indexed citations
4.
Carey, Galen, B. Costall, A.M. Domeney, et al.. (1992). Ondansetron and arecoline prevent scopolamine-induced cognitive deficits in the marmoset. Pharmacology Biochemistry and Behavior. 42(1). 75–83. 51 indexed citations
5.
Tyers, M.B. & Andrew Freeman. (1992). Mechanism of the Anti-Emetic Activity of 5-HT<sub>3</sub> Receptor Antagonists. Oncology. 49(4). 263–268. 70 indexed citations
6.
Lane, Jon D., Chris Pickering, M. Hooper, et al.. (1992). Failure of ondansetron to block the discriminative or reinforcing stimulus effects of cocaine in the rat. Drug and Alcohol Dependence. 30(2). 151–162. 56 indexed citations
7.
Jones, Brian, et al.. (1991). The pharmacology of fluparoxan: a selective α2‐adrenoceptor antagonist. British Journal of Pharmacology. 102(4). 887–895. 25 indexed citations
8.
Kilpatrick, Gavin J., et al.. (1990). [3H] GR67330, a very high affinity ligand for 5-HT3 receptors. Naunyn-Schmiedeberg s Archives of Pharmacology. 342(1). 22–30. 25 indexed citations
9.
Tyers, M.B.. (1990). 5‐HT3 Receptors. Annals of the New York Academy of Sciences. 600(1). 194–205. 27 indexed citations
10.
Burridge, Jane M., et al.. (1990). The pharmacological characterization of 5‐HT3 receptors in three isolated preparations derived from guinea‐pig tissues. British Journal of Pharmacology. 101(3). 591–598. 90 indexed citations
11.
Barnes, Janine M., Nicholas M. Barnes, B. Costall, et al.. (1990). Identification and distribution of 5-HT3 recognition sites within the human brainstem. Neuroscience Letters. 111(1-2). 80–86. 43 indexed citations
12.
Costall, B., Brian Jones, M.E. Kelly, et al.. (1990). Ondansetron inhibits a behavioural consequence of withdrawing from drugs of abuse. Pharmacology Biochemistry and Behavior. 36(2). 339–344. 100 indexed citations
13.
Barnes, Janine M., Nicholas M. Barnes, B. Costall, R.J. Naylor, & M.B. Tyers. (1989). 5-HT3 receptors mediate inhibition of acetylcholine release in cortical tissue. Nature. 338(6218). 762–763. 214 indexed citations
14.
Costall, B., M.E. Kelly, R.J. Naylor, E.S. Onaivi, & M.B. Tyers. (1989). Neuroanatomical sites of action of 5‐HT3 receptor agonist and antagonists for alteration of aversive behaviour in the mouse. British Journal of Pharmacology. 96(2). 325–332. 93 indexed citations
15.
Jones, Brian J., B. Costall, A.M. Domeney, et al.. (1988). The potential anxiolytic activity of GR38032F, a 5‐HT3‐receptor antagonist. British Journal of Pharmacology. 93(4). 985–993. 282 indexed citations
16.
Hill, Julia M., et al.. (1988). Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptors. British Journal of Pharmacology. 94(2). 397–412. 329 indexed citations
17.
Hayes, Ann G., M. Skingle, & M.B. Tyers. (1987). Evaluation of the receptor selectivities of opioid drugs by investigating the block of their effect on urine output by beta-funaltrexamine.. Journal of Pharmacology and Experimental Therapeutics. 240(3). 984–988. 16 indexed citations
18.
Kilpatrick, Gavin J., Brian Jones, & M.B. Tyers. (1987). Identification and distribution of 5-HT3 receptors in rat brain using radioligand binding. Nature. 330(6150). 746–748. 746 indexed citations breakdown →
19.
Marriott, A.S., M. Skingle, & M.B. Tyers. (1975). Proceedings: Evaluation of narcotic and narcotic antagonist analgesic drugs in the dog dental pulp stimulation test.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 55(2). 314P–314P. 1 indexed citations
20.
BLOGG, C. E., R T Brittain, B. R. Simpson, & M.B. Tyers. (1975). Proceedings: AH 10407: a novel, short-acting, competitive neuromuscular blocking drug in animals and man.. British Journal of Pharmacology. 53(3). 446. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026